Patent · US Expired

ASP1

US6025180A · kind A · utility

36Cited by
0References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 6, 1997
Grant dateFeb 15, 2000
Priority date
Expiry dateOct 6, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

ASP1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP1 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimers's Disease, cancer, and melanoma, among others, and diagnostic assays for such conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.